Exercise and Physical Activity in Children with Pediatric Acquired Brain Injury
Launched by UNIVERSIDADE DA CORUÑA · Jan 29, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the effects of exercise and physical activity on children who have suffered from acquired brain injuries. The goal is to understand how participating in physical activities can help improve their health and recovery. The study is not yet recruiting participants, but it aims to include children under 18 years old who have a medical diagnosis of a pediatric acquired brain injury and can safely participate in exercise programs.
To be eligible to join the trial, children must have consent from their guardians and be in a health condition that allows them to safely engage in physical activities. However, those with certain medical issues, like severe heart or breathing problems, or those who have difficulties in communication, will not be included. If children can attend and participate in at least 70% of the exercise sessions, they can expect to be part of an exciting program that could help them in their recovery journey.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Be under 18 years of age and present a medical diagnosis of pediatric acquired brain injury.
- • Have the informed consent completed and signed
- • Present a state that allows following indications for the practice of exercise and physical-sports activity.
- Exclusion Criteria:
- • Have medical comorbidities that contraindicate the safe performance of the program (i.e., cardiac or respiratory instability, uncontrolled seizures).
- • Have additional disabling conditions, such as cognitive impairment and/or an inability to communicate with the researcher verbally, in writing, or through an emissary.
- • Non-attendance and/or non-collaboration at 70% of the sessions of the program.
About Universidade Da Coruña
Universidade da Coruña is a prominent academic institution located in Spain, dedicated to advancing research and education across various disciplines, including health sciences. As a clinical trial sponsor, the university leverages its robust faculty expertise and state-of-the-art facilities to conduct innovative research aimed at improving patient outcomes and enhancing medical knowledge. With a strong commitment to ethical standards and regulatory compliance, Universidade da Coruña fosters collaboration between researchers, clinicians, and industry partners to facilitate the development of novel therapies and interventions, ultimately contributing to the betterment of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported